Astellas Pharma Inc. announced that its Board of Directors approved a change in its Representative Director, President and CEO. Yoshihiko Hatanaka changed position from Representative Director, President and CEO to Representative Director, Chairman of the Board. Kenji Yasukawa changed position from Representative Director, Executive Vice President to Representative Director, President and CEO.

Effective date from April 1, 2018. The changes enable Astellas to vigorously pursue the new strategic plan, which is set to start in the fiscal year 2018, aiming to realize the Astellas' Vision of being on the forefront of healthcare change to turn innovative science into value for patients.